Health Care & Wellness

Health care is a fundamental right and our goal must be to ensure that every American has access to quality, affordable care, no matter their means or where they’re from.

New Mexico faces significant health challenges, including access to care in rural and tribal communities, limited mental health services, and an opioid addiction epidemic. Our state can’t afford to see the impacts of reckless repeal of the Affordable Care Act or efforts to dismantle our nation’s health care system and gut Medicare and Medicaid.

As a proud supporter of the Affordable Care Act, I know prevention and early intervention are cost effective and lead to healthier families. Health insurance, prevention, and value for your health care dollars are at the heart of the health reform law. I am committed to working with anyone, regardless of party, to advance measures that improve health care access, quality, and affordability. The goal of revising the ACA should be to lower costs for those who already have health benefits and expand access to those who do not currently have coverage.

Latest

  • Heinrich Urges HHS To Provide More Transparency On Distribution Of Remdesivir

    WASHINGTON - U.S. Senator Martin Heinrich (D-N.M.) along with 12 of his Senate colleagues sent a letter to the Department of Health and Human Services (HHS) seeking transparency and information regarding the distribution process for remdesivir, a antiviral drug that could modestly speed recovery in patients infected with the coronavirus. The Senators cited significant concerns raised by hospitals, health providers, patients, and medical societies regarding the opaque process under which the federal government is determining distribution of remdesivir, as well as the future supply to meet patient needs. Given the likely federal role in distributing future COVID-19 drugs and vaccines, the Senators requested a briefing by May 19 from the Administration officials in charge of the remdesivir allocation process. Read More

  • NM Delegation Announces Over $77 Million for COVID-19 Testing and Contact Tracing

    WASHINGTON-Today, U.S. Senators Tom Udall (D-N.M.) and Martin Heinrich (D-N.M.), along with U.S. Representatives Ben Ray Luján (D-N.M.), Deb Haaland (D-N.M.) and Xochitl Torres Small (D-N.M.), announced that the state of New Mexico will receive over $77 million for COVID-19 testing and contact tracing from the U.S. Department of Health and Human Services. The funds are from the $25 billion for national testing and contact tracing, funding for national health care providers and hospitals and small business relief package that Congress passed in April. Read More

  • NM Delegation Announces Over $77 Million for COVID-19 Testing and Contact Tracing

    WASHINGTON-Today, U.S. Senators Tom Udall (D-N.M.) and Martin Heinrich (D-N.M.), along with U.S. Representatives Ben Ray Luján (D-N.M.), Deb Haaland (D-N.M.) and Xochitl Torres Small (D-N.M.), announced that the state of New Mexico will receive over $77 million for COVID-19 testing and contact tracing from the U.S. Department of Health and Human Services. The funds are from the $25 billion for national testing and contact tracing, funding for national health care providers and hospitals and small business relief package that Congress passed in April. Read More

  • Udall, Heinrich Join Court Filing to Protect Americans’ Health Care As Republicans Attempt To Rip Coverage From Millions Amid Coronavirus Pandemic

    WASHINGTON - U.S. Senators Tom Udall (D-N.M.) and Martin Heinrich (D-N.M.) joined the entire Senate Democratic caucus in filing an amicus brief in the case of California v. Texas (formerly Texas v. Azar). The case brought by several Republican Attorneys General and the Trump administration is currently pending before the Supreme Court and represents a direct threat to the Affordable Care Act and health care coverage for hundreds of millions of Americans.  Read More

  • Virtual Town Hall with Senators Tom Udall and Martin Heinrich

    ALBUQUERQUE, N.M. (KRQE) -KRQE Media Group hosted a Special Virtual Town Hall on COVID-19 featuring both of New Mexico's U.S. Senators Wednesday, May 13. U.S. Senator Tom Udall (D) and U.S. Senator Martin Heinrich (D) addressed the federal response to the coronavirus pandemic. The senators also answered questions from viewers that were submitted over the weekend. Read More

  • NM Delegation Announces $6.6 Million in Grants to 16 Community Health Centers for COVID-19 Relief and Testing

    WASHINGTON-U.S. Senators Tom Udall (D-N.M.) and Martin Heinrich (D-N.M.) and U.S. Representatives Ben Ray Lujan (D-N.M.), Deb Haaland (D-N.M.) and Xochitl Torres Small (D-N.M.) announced the U.S. Department of Health and Human Services (HHS) has awarded $6,626,899 to 16 New Mexico community health centers, Tribal health centers and Urban Indian Organizations to expand COVID-19 testing capacity and procure medical supplies. The funding will be used to acquire additional personal protective equipment (PPE), train staff, purchase and administer coronavirus tests, and other essential lab services. These funds come from the interim economic relief package Congress passed in April. Read More

  • Heinrich: Remdesivir on its way to New Mexico

    NEW MEXICO (KRQE) - New Mexico Senator Martin Heinrich announced Saturday that the state will soon receive its first shipment of remdesivir, an antiviral drug that could modestly speed recovery in patients infected with the coronavirus. Heinrich has reportedly been working with UNMH and the New Mexico Department of Health to secure remdesivir for the state. Read More

  • N.M. Delegation Introduces Tribal COVID-19 Disaster Assistance Cost Share Relief Act

    WASHINGTON - U.S. Senator Martin Heinrich led the New Mexico delegation, including U.S. Senator Tom Udall and U.S. Representatives Ben Ray Luján, Deb Haaland and Xochitl Torres Small, in introducing the bipartisan Tribal COVID-19 Disaster Assistance Cost Share Relief Act, legislation to eliminate the non-federal cost share for emergency protective measures undertaken by Tribal governments in response to the novel coronavirus 2019 (COVID-19). Read More